Evaluation on the Policy Effect of the Chinese Pharmaceutical Price Reform Based on Difference-in-Difference Model / 中国卫生经济

ABSTRACT

Objective:To evaluate the policy effect of the pharmaceutical price reform which implemented in May 2015 and fill the vacancy of domestic empirical studies of the reform.Methods:Two difference-in-difference(DID) models were constructed by us ing pharmaceutical related price indexes between January 2011 and February 2017 for studying the policy effect of pharmaceutical price reform.Results:Two DID models of prices and fluctuation rate both had a significantly positive DID estimator.The drug price re form improved the prices and fluctuation rate of domestic drug.Conclusion:In the short-term,the reform could not reduce pharmaceu tical price and release medical burden.However,from the aspect of economics,market pricing brought market competition which could form a reasonable pharmaceutical price in the long-run and had positive impacts on the development of the medical market.